- Home
- SCLX vs CLPR Comparison
SCLX vs CLPR Comparison
Compare SCLX & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- CLPR
- Stock Information
- Founded
- SCLX 2011
- CLPR 2015
- Country
- SCLX United States
- CLPR United States
- Employees
- SCLX N/A
- CLPR N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- SCLX Health Care
- CLPR Real Estate
- Exchange
- SCLX Nasdaq
- CLPR Nasdaq
- Market Cap
- SCLX 81.7M
- CLPR 77.0M
- IPO Year
- SCLX N/A
- CLPR 2017
- Fundamental
- Price
- SCLX $0.48
- CLPR $6.20
- Analyst Decision
- SCLX Strong Buy
- CLPR Sell
- Analyst Count
- SCLX 3
- CLPR 2
- Target Price
- SCLX $11.33
- CLPR N/A
- AVG Volume (30 Days)
- SCLX 184.3K
- CLPR 135.8K
- Earning Date
- SCLX 12-24-2024
- CLPR 10-31-2024
- Dividend Yield
- SCLX N/A
- CLPR 6.23%
- EPS Growth
- SCLX N/A
- CLPR N/A
- EPS
- SCLX N/A
- CLPR N/A
- Revenue
- SCLX $50,833,000.00
- CLPR $145,595,000.00
- Revenue This Year
- SCLX $32.77
- CLPR N/A
- Revenue Next Year
- SCLX $50.71
- CLPR N/A
- P/E Ratio
- SCLX N/A
- CLPR N/A
- Revenue Growth
- SCLX 9.41
- CLPR 6.78
- 52 Week Low
- SCLX $0.46
- CLPR $3.38
- 52 Week High
- SCLX $2.63
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- SCLX 33.34
- CLPR 66.88
- Support Level
- SCLX $0.48
- CLPR $4.32
- Resistance Level
- SCLX $0.54
- CLPR $6.49
- Average True Range (ATR)
- SCLX 0.06
- CLPR 0.35
- MACD
- SCLX -0.00
- CLPR 0.20
- Stochastic Oscillator
- SCLX 4.53
- CLPR 87.79
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.